Skip to main content
. 2022 Aug 5;10:887076. doi: 10.3389/fcell.2022.887076

TABLE 2.

Top 6 small molecular drug candidates for HCC treatments.

Name Cell line Major introduction Major function Correlation score
Mebendazole Huh7 Mebendazole is a synthetic benzimidazole derivate and anthelmintic agent. It is used commonly for parasitic worm infections. Tubulin inhibitor −0.57
Albendazole Huh7 Albendazole is a benzimidazole medication used for the treatment of a variety of parasitic worm infestations. Tubulin inhibitor −0.52
Vinorelbine Huh7 Vinorelbine is a semisynthetic vinca alkaloid. Vinorelbine binds to tubulin and prevents formation of the mitotic spindle, resulting in the arrest of tumor cell growth in metaphase. Tubulin inhibitor −0.52
Vinblastine HepG2 Antitumor alkaloid isolated from Vinca rosea. It binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. Tubulin inhibitor −0.52
Vindesine Huh7 Vindesine is an anti-mitotic vinca alkaloid used in chemotherapy. It is used to treat many different types of cancer. Tubulin inhibitor −0.50
Vincristine Huh7 Vincristine is a vinca alkaloid and used as a chemotherapy drug. It has a role as a tubulin modulator, a microtubule-destabilizing agent. Tubulin inhibitor −0.46